Australia markets closed

Beijing Balance Medical Technology Co.,Ltd. (688198.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
97.82-0.42 (-0.43%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 13.44B
Enterprise value 13.15B
Trailing P/E 125.41
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)33.85
Price/book (mrq)11.87
Enterprise value/revenue 33.39
Enterprise value/EBITDA 104.22

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3-25.91%
S&P500 52-week change 320.52%
52-week high 3144.00
52-week low 392.55
50-day moving average 398.95
200-day moving average 3112.44

Share statistics

Avg vol (3-month) 3157.28k
Avg vol (10-day) 391.69k
Shares outstanding 5137.4M
Implied shares outstanding 6137.4M
Float 835.86M
% held by insiders 173.64%
% held by institutions 110.50%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.82%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.81%
5-year average dividend yield 4N/A
Payout ratio 4102.56%
Dividend date 3N/A
Ex-dividend date 428 May 2024
Last split factor 21.4:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 26.97%
Operating margin (ttm)22.39%

Management effectiveness

Return on assets (ttm)4.21%
Return on equity (ttm)8.44%

Income statement

Revenue (ttm)393.68M
Revenue per share (ttm)2.89
Quarterly revenue growth (yoy)11.40%
Gross profit (ttm)N/A
EBITDA 97.59M
Net income avi to common (ttm)106.18M
Diluted EPS (ttm)0.78
Quarterly earnings growth (yoy)-17.40%

Balance sheet

Total cash (mrq)310.93M
Total cash per share (mrq)2.28
Total debt (mrq)11.45M
Total debt/equity (mrq)1.02%
Current ratio (mrq)5.71
Book value per share (mrq)8.29

Cash flow statement

Operating cash flow (ttm)62M
Levered free cash flow (ttm)-70.22M